NO20076411L - Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme - Google Patents

Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme

Info

Publication number
NO20076411L
NO20076411L NO20076411A NO20076411A NO20076411L NO 20076411 L NO20076411 L NO 20076411L NO 20076411 A NO20076411 A NO 20076411A NO 20076411 A NO20076411 A NO 20076411A NO 20076411 L NO20076411 L NO 20076411L
Authority
NO
Norway
Prior art keywords
organic compounds
radioactive halogen
amino
methods
same
Prior art date
Application number
NO20076411A
Other languages
English (en)
Inventor
Masahito Toyama
Fumie Kurosaki
Akio Hayashi
Osamu Ito
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20076411L publication Critical patent/NO20076411L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen tilveiebringer en merkingsforløperforbindelse anvendt for selektivt å fremstille radioaktive halogensubstituerte syn-l-amino-3-cyklobutan-karboksylsyrer og å tilveiebringe en prosess for fremstilling av en radioaktivt halogensubstituert syn-l-amino-3-cyklobutan-karboksylsyre ved bruk av merkingsforløperforbindelsen. En merkingsforløper anvendes hvori ftalimidgruppen anvendes som en beskyttende gruppe for å beskytte aminogruppen. Syn-formen av den radioaktivt halogensubstituerte l-amino-3-cyklobutan-karboksylsyre kan selektivt fremstilles ved merking av merkingsforløperen med et radioaktivt halogen etterfulgt av avbeskyttelse.
NO20076411A 2005-05-23 2007-12-12 Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme NO20076411L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005149186 2005-05-23
PCT/JP2006/309643 WO2006126410A1 (ja) 2005-05-23 2006-05-15 新規有機化合物及び該化合物を利用した放射性ハロゲン標識有機化合物の製造方法

Publications (1)

Publication Number Publication Date
NO20076411L true NO20076411L (no) 2008-02-13

Family

ID=37451836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076411A NO20076411L (no) 2005-05-23 2007-12-12 Nye organiske forbindelser og fremgangsmate for a fremstille radioaktive halogenmerkede organiske forbindelser anvendende samme

Country Status (14)

Country Link
US (1) US7910745B2 (no)
EP (1) EP1889834B1 (no)
JP (1) JP4989467B2 (no)
KR (1) KR101315152B1 (no)
CN (1) CN101180272B (no)
AT (1) ATE506347T1 (no)
AU (1) AU2006250594B2 (no)
CA (1) CA2608919C (no)
DE (1) DE602006021418D1 (no)
DK (1) DK1889834T3 (no)
ES (1) ES2364463T3 (no)
NO (1) NO20076411L (no)
TW (1) TWI410396B (no)
WO (1) WO2006126410A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
RU2428415C2 (ru) 2005-11-29 2011-09-10 Нихон Меди-Физикс Ко., Лтд. Соединение-предшественник органического соединения, меченного радиоактивным галогеном
US8790620B2 (en) * 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
BRPI0720465B8 (pt) * 2006-12-27 2021-07-27 Nihon Mediphysics Co Ltd processo para produção de composto de precursor para composto orgânico marcado com halogênio radioativo
EP2119458B9 (en) * 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
JP5121349B2 (ja) * 2007-08-10 2013-01-16 株式会社トクヤマ アミノ酸の製造方法
CN102471235A (zh) * 2009-07-11 2012-05-23 拜耳医药股份有限公司 利用环烷基的放射性标记方法
CN103167884A (zh) 2010-10-28 2013-06-19 通用电气健康护理有限公司 用干燥剂稳定放射性药物前体
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
WO2018235535A1 (ja) * 2017-06-23 2018-12-27 日本メジフィジックス株式会社 放射性ハロゲン標識化合物の製造方法および放射性医薬の製造方法
CN110724058A (zh) * 2019-10-25 2020-01-24 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法
US12404229B2 (en) 2019-10-25 2025-09-02 Jilin Asymchem Pharmaceuticals Co., Ltd. Preparation method for trans-cyclobutane-o-dicarboxylic acid ester and derivative thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids

Also Published As

Publication number Publication date
JP4989467B2 (ja) 2012-08-01
ES2364463T3 (es) 2011-09-02
KR20080016557A (ko) 2008-02-21
CN101180272A (zh) 2008-05-14
WO2006126410A1 (ja) 2006-11-30
ATE506347T1 (de) 2011-05-15
TW200704630A (en) 2007-02-01
EP1889834B1 (en) 2011-04-20
CN101180272B (zh) 2012-04-25
KR101315152B1 (ko) 2013-10-07
HK1117529A1 (en) 2009-01-16
DE602006021418D1 (de) 2011-06-01
DK1889834T3 (da) 2011-08-08
AU2006250594B2 (en) 2011-06-16
US7910745B2 (en) 2011-03-22
CA2608919A1 (en) 2006-11-30
JPWO2006126410A1 (ja) 2008-12-25
EP1889834A1 (en) 2008-02-20
EP1889834A4 (en) 2010-06-30
AU2006250594A1 (en) 2006-11-30
CA2608919C (en) 2012-11-20
US20090105489A1 (en) 2009-04-23
TWI410396B (zh) 2013-10-01

Similar Documents

Publication Publication Date Title
Meinert et al. Photochirogenesis: Photochemical models on the absolute asymmetric formation of amino acids in interstellar space
BR112013000085A2 (pt) processo para a preparação de sal derivado de diamina opticamente ativo
BRPI0516221A (pt) método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso
EA200901322A1 (ru) Пиридонкарбоксамиды, содержащие их средства защиты растений, а также способ их получения и их применение
AR098260A2 (es) Polimorfo cristalino de una sal de bisulfato de un antagonista del receptor de trombina, proceso para su preparación, composición y forma purificada
BR0309659A (pt) Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
SA114350283B1 (ar) مثبطات بروتياز كيتونية ايبوكسي ترابيبتيد بلورية
WO2009020199A1 (ja) 鉛フリーハンダフラックス除去用洗浄剤組成物、および鉛フリーハンダフラックスの除去方法
EP2412700A4 (en) PROCESS FOR PREPARING A BICYCLIC GAMMA AMINO ACID DERIVATIVE
NZ606001A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
EA201890254A3 (ru) Ингибиторы глюкозилцерамидсинтазы
AR084433A1 (es) Inhibidores de la faah y composiciones farmaceuticas que los contienen
EA201171216A1 (ru) Фенилацетат l-орнитина и способы его получения
PL2044003T3 (pl) Sposób przekształcania pierwszorzędnych amidoalkoholi w kwasy amidokarboksylowe z wysoką wydajnością z użyciem wody jako rozpuszczalnika
WO2012031045A3 (en) Phosphonate ester derivatives and methods of synthesis thereof
PH12013502177A1 (en) Hepatitis c virus inhibitors
NZ602872A (en) Crystalline peptide epoxyketone immunoproteasome inhibitor
BR112014001371A2 (pt) fermentação de glicerol para ácidos orgânicos
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
DK1889834T3 (da) Ny organisk forbindelse og fremgangsmåde til at fremstille radioaktiv halogenmærket organisk forbindelse ved anvendelse af samme
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
NO20092389L (no) Fremgangsmate for fremstilling av precursorforbindelse for radioaktivt halogenmerket organisk forbindelse
TW200738271A (en) Methods of making radiolabeled tracers and precursors thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application